A noncontrolled trial of anti-TNF-α chimeric monoclonal antibody (infliximab, Remicade(®)) in exudative age-related macular degeneration

P Martin van Hagen; G Seerp Baarsma; Christel E van Bilsen; Robert W Kuijpers; Jan A van Laar; Marianne van der Ent; Paul L van Daele; Nico J Veeger; Johannes R Vingerling; Tom O Missotten

doi:10.1111/aos.12471

A noncontrolled trial of anti-TNF-α chimeric monoclonal antibody (infliximab, Remicade(®)) in exudative age-related macular degeneration

P Martin van Hagen
, G Seerp Baarsma
, Christel E van Bilsen
, Robert W Kuijpers
, Jan A van Laar
, Marianne van der Ent
, Paul L van Daele
, Nico J Veeger
, Johannes R Vingerling
, Tom O Missotten

Medical retina and Uveitis

Onderzoeksoutput: Bijdrage aan tijdschrift › Brief › peer review

Originele taal-2	Engels
Pagina's (van-tot)	e691-2
Tijdschrift	Acta Ophthalmologica
Volume	92
Nummer van het tijdschrift	8
DOI's	https://doi.org/10.1111/aos.12471
Status	Gepubliceerd - dec 2014

Toegang tot document

10.1111/aos.12471

Citeer dit

van Hagen, P. M., Baarsma, G. S., van Bilsen, C. E., Kuijpers, R. W., van Laar, J. A., van der Ent, M., van Daele, P. L., Veeger, N. J., Vingerling, J. R., & Missotten, T. O. (2014). A noncontrolled trial of anti-TNF-α chimeric monoclonal antibody (infliximab, Remicade(®)) in exudative age-related macular degeneration. Acta Ophthalmologica, 92(8), e691-2. https://doi.org/10.1111/aos.12471

@article{f4f6b56fd62045ac9136b812e5601dd4,

title = "A noncontrolled trial of anti-TNF-α chimeric monoclonal antibody (infliximab, Remicade({\textregistered})) in exudative age-related macular degeneration",

keywords = "Administration, Topical, Aged, Anti-Inflammatory Agents, Non-Steroidal/adverse effects, Antibodies, Monoclonal/adverse effects, Contrast Sensitivity/drug effects, Exudates and Transudates, Humans, Infliximab, Ophthalmic Solutions, Tumor Necrosis Factor-alpha, Visual Acuity/drug effects, Wet Macular Degeneration/drug therapy",

author = "\{van Hagen\}, \{P Martin\} and Baarsma, \{G Seerp\} and \{van Bilsen\}, \{Christel E\} and Kuijpers, \{Robert W\} and \{van Laar\}, \{Jan A\} and \{van der Ent\}, Marianne and \{van Daele\}, \{Paul L\} and Veeger, \{Nico J\} and Vingerling, \{Johannes R\} and Missotten, \{Tom O\}",

year = "2014",

month = dec,

doi = "10.1111/aos.12471",

language = "English",

volume = "92",

pages = "e691--2",

number = "8",

}

van Hagen, PM, Baarsma, GS, van Bilsen, CE, Kuijpers, RW, van Laar, JA, van der Ent, M, van Daele, PL, Veeger, NJ, Vingerling, JR & Missotten, TO 2014, 'A noncontrolled trial of anti-TNF-α chimeric monoclonal antibody (infliximab, Remicade(®)) in exudative age-related macular degeneration', Acta Ophthalmologica, vol. 92, nr. 8, blz. e691-2. https://doi.org/10.1111/aos.12471

TY - JOUR

T1 - A noncontrolled trial of anti-TNF-α chimeric monoclonal antibody (infliximab, Remicade(®)) in exudative age-related macular degeneration

AU - van Hagen, P Martin

AU - Baarsma, G Seerp

AU - van Bilsen, Christel E

AU - Kuijpers, Robert W

AU - van Laar, Jan A

AU - van der Ent, Marianne

AU - van Daele, Paul L

AU - Veeger, Nico J

AU - Vingerling, Johannes R

AU - Missotten, Tom O

PY - 2014/12

Y1 - 2014/12

KW - Administration, Topical

KW - Aged

KW - Anti-Inflammatory Agents, Non-Steroidal/adverse effects

KW - Antibodies, Monoclonal/adverse effects

KW - Contrast Sensitivity/drug effects

KW - Exudates and Transudates

KW - Humans

KW - Infliximab

KW - Ophthalmic Solutions

KW - Tumor Necrosis Factor-alpha

KW - Visual Acuity/drug effects

KW - Wet Macular Degeneration/drug therapy

U2 - 10.1111/aos.12471

DO - 10.1111/aos.12471

M3 - Letter

C2 - 24953977

SN - 1755-375X

VL - 92

SP - e691-2

JO - Acta Ophthalmologica

JF - Acta Ophthalmologica

IS - 8

ER -